Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Infections 9 Lymphoma 7 Leukemia 6 Neoplasms, Plasma Cell 5 Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Urinary Tract Infections 2 Prostatic Neoplasms 2 Leukemia, Biphenotypic, Acute 2 Waldenstrom Macroglobulinemia 1 Urinary Bladder Neoplasms 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Thrombocythemia, Essential 1 Surgical Wound Infection 1 Skin Neoplasms 1 Sezary Syndrome 1 Sepsis 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Lymphoproliferative Disorders 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Mantle-Cell 1

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 1 Trimethoprim 1 Nitrofurantoin 1 Linezolid 1 Fluconazole 1 Ciprofloxacin 1 Cefuroxime 1 Amoxicillin-Potassium Clavulanate Combination 1 Amoxicillin 1 Amdinocillin Pivoxil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Cystectomy × Trimethoprim, Sulfamethoxazole Drug Combination × Clear all

NCT06709196 2025-01-09

REINFORCE

Rigshospitalet, Denmark

Phase 4 Recruiting

Cystectomy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡